She is an internationally known expert in lung cancer, precision cancer care and immunotherapy in which she has published numerous clinical trials, research papers and consensus statements.
During her time at Osler she advanced the oncology program by starting innovative programs such as the Osler Cancer Immunotherapy Program and led the growth of oncology clinical trials to become a Canadian leader in oncology trials recruitment and offers patients at Osler state-of-the-art treatments through global clinical trials. In strong collaboration with her pathology colleagues her work and advocacy solidified partnerships that enabled the ability for Osler to offer the most advanced genomics for cancer care in Canada.